Zhejiang Gongdong Medical Technology (605369.SH): The controlling shareholder Shi Huiyong plans to reduce his holdings by no more than 2% through a bulk trade.

Zhejiang Gongdong Medical Technology (605369.SH) announced that the controlling shareholder Shi Huiyong planned to reduce the company's holdings by no more than 2,252,300 shares through block trading within 3 months after 15 trading days from the date of this announcement, and the total number of shares sold during any consecutive 90-day period shall not exceed 2% of the company's total share capital. The sale price will be determined based on the market price at the time of the sale.

Gelonghui FinanceJun 13 04:44 ET

Zhejiang Gongdong Medical Technology (SHSE:605369) Will Want To Turn Around Its Return Trends

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Typically, we'll want to notice a trend of growing return on capi

Simply Wall StJun 7 19:22 ET

Gongdong Medical (605369.SH): The holding subsidiary was incorporated in Gongdong, Zhengzhou

Gelonghui, May 13丨Gongdong Medical (605369.SH) announced that recently, Gongdong, Zhengzhou has obtained a “Business License” issued by the Market Supervision Administration of the Zhengzhou Airport Economic Comprehensive Pilot Zone. The registered capital of Zhengzhou Gongdong is RMB 60 million, of which the company has pledged RMB 42 million, accounting for 70% of the registered capital; Antu Biotech has pledged a capital of RMB 18 million, accounting for 30% of the registered capital. An important customer of the shareholder Antu Biotech. Gongdong, Zhengzhou, which was invested and established by the company this time will focus on R&D, production of medical polymer consumables and related products and services

Gelonghui FinanceMay 13 04:01 ET

Gongdong Medical (605369.SH) announced first-quarter results, net profit of 45.109 million yuan, an increase of 56.02% over the previous year

Zhitong Finance App News, Gongdong Healthcare (605369.SH) released its report for the first quarter of 2024. The company's revenue was 272 million yuan, up 20.22% year on year; net profit attributable to shareholders of listed companies was 45.109 million yuan, up 56.02% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 43.445 million yuan, up 85.73% year on year; basic earnings per share were 0.40 yuan/share.

Zhitong FinanceApr 26 03:54 ET

The Price Is Right For Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369)

With a price-to-earnings (or "P/E") ratio of 47x Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369) may be sending very bearish signals at the moment, given that almost half of all companies

Simply Wall StApr 18 21:32 ET

The Recent CN¥500m Market Cap Decrease Is Likely to Have Disappointed Insiders Invested in Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369)

Key Insights Insiders appear to have a vested interest in Zhejiang Gongdong Medical Technology's growth, as seen by their sizeable ownership The largest shareholder of the company is Huiyong Shi wit

Simply Wall StMar 27 19:53 ET